(Q42429273)

31 October 2017

0 references

Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation (English)

1 reference

31 October 2017

0 references

liver transplantation

1 reference

based on heuristic

inferred from title

author

Alexander N Shoushtari

object named as

Alexander N Shoushtari

0 references

author name string

Rita E Morales

1

1 reference

31 October 2017

Michelle M Walsh

3

1 reference

31 October 2017

Priya Grewal

4

1 reference

31 October 2017

Evan J Lipson

5

1 reference

31 October 2017

Richard D Carvajal

6

1 reference

31 October 2017

16 June 2015

1 reference

Journal for Immunotherapy of Cancer

31 October 2017

1 reference

31 October 2017

3

1 reference

31 October 2017

22

1 reference

Creative Commons Attribution 4.0 International

31 October 2017

start time

16 June 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

Systematic review of melanoma incidence and prognosis in solid organ transplant recipients

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469313

10.1186/S40425-015-0066-0

16 August 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 October 2017

0 references

1 reference

31 October 2017

PubMed publication ID

26082835

1 reference